Product Program year 2019 Source: CMS Open Payments

Zemdri (Plazomicin)

Drug Antibiotics

NDC 69097-820-37

Open in the dashboard

General payments

$5,449

25 payments

Research payments

$0

0 payments

Through program year 2019, $5,449 in general payments and $0 in research payments were reported against Zemdri (Plazomicin) (Antibiotics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $5,449 25

Breakdown

Who paid General payments · program year 2019
  1. Cipla USA Inc. $5,449 25 payments
Top recipients General payments · program year 2019
  1. Kitonga Kiminyo Infectious Disease · Boynton Beach, FL $615 11% · 2 payments
  2. Imad Omer Infectious Disease · Memphis, TN $495 9% · 1 payment
  3. Stephen Threlkeld Infectious Disease · Memphis, TN $495 9% · 1 payment
  4. Patrick Anastasio Infectious Disease · Fort Walton Beach, FL $449 8% · 2 payments
  5. Shaker Itani Infectious Disease · Las Vegas, NV $377 7% · 1 payment

The top 5 of 21 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Infectious Disease Internal Medicine $4,862 89% · 18 practitioners
  2. Pulmonary Disease Internal Medicine $464 9% · 2 practitioners
  3. Internal Medicine $124 2% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2019
  1. Florida $2,479 45% · 7 recipients
  2. Tennessee $991 18% · 2 recipients
  3. California $934 17% · 6 recipients
  4. Indiana $377 7% · 1 recipient
  5. Nevada $278 5% · 2 recipients

The top 5 of 7 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

25 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record